Total Payments
$5,629
2024 Payments
$134.77
Companies
46
Transactions
366
Medicare Patients
4,200
Medicare Billing
$704,708
Payment Breakdown by Category
Food & Beverage$5,340 (94.9%)
Education$288.59 (5.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,340 | 357 | 94.9% |
| Education | $288.59 | 9 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $636.21 | 59 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $538.51 | 39 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $402.14 | 32 | $0 (2019) |
| Genentech USA, Inc. | $382.40 | 26 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $329.33 | 36 | $0 (2019) |
| Millennium Pharmaceuticals, Inc. | $315.67 | 4 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $243.20 | 12 | $0 (2023) |
| Amgen Inc. | $236.69 | 14 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $235.63 | 10 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $224.90 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.77 | 2 | Haemonetics Corporation ($120.41) |
| 2023 | $117.08 | 2 | AstraZeneca Pharmaceuticals LP ($100.00) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2019 | $1,193 | 76 | PFIZER INC. ($176.83) |
| 2018 | $2,274 | 161 | Merck Sharp & Dohme Corporation ($238.93) |
| 2017 | $1,898 | 124 | Millennium Pharmaceuticals, Inc. ($315.67) |
All Payment Transactions
366 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: ONCOLOGY | ||||||
| 02/29/2024 | Haemonetics Corporation | TEG6S HEMOSTASIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $120.41 | General |
| Category: DEVICES | ||||||
| 04/11/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Neuromodulation | ||||||
| 03/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 11/19/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Oncology | ||||||
| 11/14/2019 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Oncology | ||||||
| 11/07/2019 | PFIZER INC. | BOSULIF (Drug), DAURISMO | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/05/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2019 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Oncology | ||||||
| 10/29/2019 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Oncology | ||||||
| 10/24/2019 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2019 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Oncology | ||||||
| 10/07/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Oncology | ||||||
| 09/18/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 09/16/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| Category: Oncology | ||||||
| 08/26/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Oncology | ||||||
| 07/31/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,105 | 2,216 | $615,197 | $159,375 |
| 2022 | 8 | 1,053 | 2,321 | $711,231 | $174,897 |
| 2021 | 9 | 1,099 | 2,290 | $733,033 | $191,975 |
| 2020 | 10 | 943 | 2,101 | $675,607 | $178,461 |
Total Patients
4,200
Total Services
8,928
Medicare Billing
$704,708
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 454 | 1,138 | $318,812 | $75,895 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 73 | 247 | $101,517 | $26,169 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 261 | 332 | $62,817 | $15,202 | 24.2% |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 2023 | 41 | 159 | $11,130 | $11,348 | 102.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $35,144 | $8,678 | 24.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 51 | $25,398 | $6,729 | 26.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 86 | $19,522 | $5,111 | 26.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 55 | $18,810 | $4,903 | 26.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $10,098 | $2,611 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $9,342 | $2,091 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,607 | $637.70 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 467 | 1,447 | $421,949 | $98,044 | 23.2% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 60 | 172 | $82,560 | $27,396 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 268 | 346 | $68,610 | $15,553 | 22.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 60 | 148 | $43,348 | $11,523 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 94 | 94 | $37,714 | $8,501 | 22.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 47 | $26,646 | $6,877 | 25.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 34 | 39 | $15,152 | $3,574 | 23.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $15,252 | $3,429 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 466 | 1,331 | $388,845 | $96,426 | 24.8% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 81 | 254 | $121,920 | $40,516 | 33.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 241 | 313 | $62,022 | $14,972 | 24.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 70 | 137 | $41,073 | $10,845 | 26.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 65 | 72 | $41,661 | $10,616 | 25.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 88 | 88 | $35,185 | $8,698 | 24.7% |
About Dr. David Cho, M.D
Dr. David Cho, M.D is a Internal Medicine healthcare provider based in Tempe, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1073777819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Cho, M.D has received a total of $5,629 in payments from pharmaceutical and medical device companies, with $134.77 received in 2024. These payments were reported across 366 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($5,340).
As a Medicare-enrolled provider, Cho has provided services to 4,200 Medicare beneficiaries, totaling 8,928 services with total Medicare billing of $704,708. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Tempe, AZ
- Active Since 07/10/2008
- Last Updated 04/01/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073777819
Products in Payments
- KEYTRUDA (Biological) $465.70
- IBRANCE (Drug) $254.10
- Imbruvica (Drug) $235.63
- OPDIVO (Biological) $192.38
- NINLARO (Drug) $179.26
- JEVTANA (Drug) $157.02
- Nerlynx (Drug) $156.77
- CYRAMZA (Drug) $142.00
- Avastin (Biological) $131.36
- SUTENT (Drug) $124.12
- Neulasta (Biological) $120.81
- XTANDI (Drug) $120.60
- TEG6S HEMOSTASIS SYSTEM (Device) $120.41
- Stivarga (Drug) $116.05
- Revlimid (Drug) $107.58
- IMBRUVICA (Drug) $101.78
- GAZYVA (Biological) $101.65
- TASIGNA (Drug) $100.05
- FARXIGA (Drug) $100.00
- BOSULIF (Drug) $86.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tempe
Jeffrey Hoodin, M.d, M.D
Internal Medicine — Payments: $206,801
Internal Medicine $206,801
Dr. Robert Bloomberg, Md, MD
Internal Medicine — Payments: $13,899
Internal Medicine $13,899
Dr. Carlos Echevarria, Md, Mmm, MD, MMM
Internal Medicine — Payments: $13,214
Internal Medicine $13,214
Dr. Kenneth Anaeme, Md, MD
Internal Medicine — Payments: $10,337
Internal Medicine $10,337
Dhaval Shah, M.d, M.D
Internal Medicine — Payments: $8,039
Internal Medicine $8,039
Dr. Shilpa Bhatnagar, M. D, M. D
Internal Medicine — Payments: $7,050
Internal Medicine $7,050